Back to 
BlackRock, Inc.
BlackRock, Inc.
KRYS7 quarters
Position history for BlackRock, Inc.'s holdings in Krystal Biotech, Inc.
BlackRock, Inc. holds 4.2M shares of KRYS (Krystal Biotech, Inc.), worth $1.6B as of 2026-Q2. The position was increased (+6.1% shares). KRYS represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$1.6B
Current Shares
4.2M
Total Value Change
+$922.2M
Total Shares Change
+147,560
Quarter-by-Quarter History
Other major holders of KRYS: FMR LLC, Avoro Capital Advisors LLC